GlassScriptPhysician profile
Evan A Odonnell
NPI 1851710487
$39,094.50
in general payments reported to CMS, 2019-2025
8 companies · $2,209 in 2025
The $2,209 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $10K · 2021: $1,251 · 2022: $435 · 2023: $2,240 · 2024: $1,531 · 2025: $2,209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,428 · Travel and Lodging: $2,552.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,428.40 |
| Travel and Lodging | $2,551.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $21,500.13 | 2019-2025 | Arthroplasty Implants Revers Total Shoulder Modular Glenoid Systems |
| Smith+Nephew, INC. | $7,650.00 | 2020 | |
| Kairos Surgical INC | $6,033.23 | 2019-2025 | |
| Stryker Corporation | $3,189.92 | 2019-2025 | Aequalis Perform, Blueprint Patient Specific Instrumentation, Aequalis Perform Reversed |
| Globus Medical, INC. | $321.96 | 2022-2023 | Proximal Humerus Strut |
| Bone Support INC. | $143.65 | 2024 | Ceramentbone Void Filler, Cerament G |
| Restor3d, INC. | $140.24 | 2024 | |
| Baxter Healthcare | $115.37 | 2025 | Floseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Odonnell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.